Currently, the standard of care for preventing neonatal GBS disease is screening pregnant women at 35–37 weeks of gestation to determine their GBS colonization status. Assay is a qualitative in vitro diagnostic test designed to detect Group B Streptococcus (GBS) DNA from enriched vaginal/rectal swab specimens
ESwab standard tip collection kit (white)
Other bacterial culture swab with Amies or Stuarts liquid transport media
Ambient (15-30°C) - 24 hours
Refrigerated (2-8°C) - 6 days
Polymerase chain reaction (PCR)
For women who have no prenatal care, who deliver preterm, or whose GBS test results are unknown at the time of delivery order Group B Strep Rapid DNA PCR, LAB8127 (GBS).